Global Antithrombin Market Opportunities and Forecast 2023-2030

Antithrombin Market Overview

The global antithrombin market is expected to grow at a moderate rate during the forecast period. Factors such as Increasing incidences of hereditary and acquired hereditary antithrombin deficiency are projected to increase the demand for the antithrombin market.

Moreover, the prevalence of cardiac diseases is expected to increase among the population due to lifestyle changes, which in turn will result in increased use of anticoagulants. Therefore, the growing usage of such antithrombin-based anticoagulants will drive the demand for antithrombin in the pharmaceutical sector.

On the other hand, the expense associated with antithrombin administration is an important practical consideration. The total cost of plasma-derived AT (Thrombate III) was approximately USD 140000. Hence, the high cost of antithrombin-based therapies to shift preference towards substitute therapies is likely to hamper the global Antithrombin market during the forecast period.

Covid-19 Impact on Antithrombin Market:

In addition, the current antithrombin market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Antithrombin Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare applications and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.

Antithrombin Market Segment Overview

Based on application, the global antithrombin market is categorized into therapeutics, research, and diagnostics. Among these therapeutics holds the largest share of the market mainly because it plays a vital role and is boosting the antithrombin therapeutics market. Moreover, the increasing prevalence of antithrombin deficiency and growing incidences of bleeding during surgeries are major factors driving the growth of the market.

Based on the source, the global antithrombin market is categorized into human and goat milk. Among these goat milk holds the largest share of the market mainly due to its proven clinical efficiency.

Based on formulation, the global antithrombin market is categorized into lyophilized and liquid. Among these lyophilized formulation is expected to dominate the market in the forecast period. The dominance of the segment owing to its high demand compared to other formulations. Antithrombin in lyophilized form provides more stability and efficiency.

Market Analysis, Insights and Forecast – By Application

·       Research and Diagnostics
·       Therapeutics

Market Analysis, Insights and Forecast – By Source

·       Human
·       Goat Milk

Market Analysis, Insights and Forecast – By Formulation

·       Lyophilized
·       Liquid

Antithrombin Market Regional Overview

Region-wise, North America dominated the global Antithrombin market and is expected to continue its dominance during the forecast period. The North American region dominates the global antithrombin market owing to the growing number of surgeries and extensive research initiatives. Furthermore, Europe is expected to hold a maximum share in the global antithrombin market due to the growing geriatric population and the presence of leading players. In Addition, a factor that is contributing to the growth of the market in this region is the significant adoption of antithrombin therapies on the back of high awareness, early availability of advanced technologies, and significant increment in national healthcare budgets.

Antithrombin Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)

Antithrombin Market Competitor overview

Some key developments and strategies adopted by manufacturers in the Antithrombin are highlighted below.

·       In September 2017, Kyowa Hakko Kirin Co. Ltd. Launched a new ACOALAN injection 1800 which is specially designed to avoid the infection caused by human blood. The main aim is to provide people new technologies which can help them to get better life and health. 

Antithrombin Market, Key Players

·       Grifols S.A
·       Axis-Shield Plc
·       CSL Limited
·       Thermo Fisher Scientific
·       Baxter International Inc
·       Shire PLC
·       Kedrion SpA
·       Octapharma AG
·       Lee Biosolutions, Inc
·       Scripps Laboratories, Inc.